{
    "nct_id": "NCT03781167",
    "official_title": "A 52-Week, Open-label, Single-arm Study to Evaluate the Safety and Tolerability of 24-hour Daily Exposure of Continuous Subcutaneous Infusion of ABBV-951 in Subjects With Parkinson's Disease",
    "inclusion_criteria": "* Participants with diagnosis of idiopathic Parkinson's Disease (PD) that is levodopa-responsive\n* Participants must be judged by the investigator to be inadequately controlled by current therapy, have recognizable/identifiable \"Off\" and \"On\" states (motor fluctuations), and have a minimum of 2.5 hours of \"Off\" time per day\nHealthy volunteers allowed\nMust have minimum age of 30 Years",
    "exclusion_criteria": "* Participant is cognitively impaired and is not able to safely and effectively manage the drug delivery system and the diaries and is not able to adhere to the study\n* Participant is considered by the investigator to be an unsuitable candidate to receive ABBV-951 for any reason",
    "miscellaneous_criteria": ""
}